{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:32:13Z","timestamp":1794108733205,"version":"4.8.0"},"reference-count":34,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"abstract":"<jats:p>A topical nanofiber nitric oxide (NO) releasing patch (\u22483.5 \u03bcmol NO\/cm<jats:sup>2<\/jats:sup>\/day for 20 days, NOP) was compared with intramuscular meglumine antimoniate (Glucantime, 20 mg\/kg\/day for 20 days) for the treatment of cutaneous leishmaniasis (CL) caused by <jats:italic>Leishmania<\/jats:italic> (<jats:italic>V.<\/jats:italic>) <jats:italic>panamensis<\/jats:italic> in Santander and Tolima, Colombia. A double-blind, randomized, placebo-controlled, clinical trial was conducted to determine whether the NOP is as effective as Glucantime for the treatment of CL. Patients were randomly assigned to Glucantime and placebo patches or NOP and placebo of Glucantime. The cure rates after a 3-month follow-up were 94.8% for the group that received Glucantime compared with 37.1% in the NOP group. Despite the lower efficacy of the NOP versus Glucantime, a significantly lower frequency of non-serious adverse events and a reduced variation in serum markers were observed in patients treated with NOP. Treatment of CL with NOP resulted in a lower effectiveness compared with Glucantime; however, the low frequency of adverse events and the facility of topic administration justify the development of new generations of NOP systems for the treatment of CL.<\/jats:p>","DOI":"10.4269\/ajtmh.2010.09-0287","type":"journal-article","created":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T16:25:01Z","timestamp":1278001501000},"page":"97-101","source":"Crossref","is-referenced-by-count":47,"title":["A Controlled, Randomized-Blinded Clinical Trial to Assess the Efficacy of a Nitric Oxide Releasing Patch in the Treatment of Cutaneous Leishmaniasis by Leishmania (V.) panamensis"],"prefix":"10.4269","volume":"83","author":[{"given":"Patricio","family":"L\u00f3pez-Jaramillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin Y.","family":"Rinc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald G.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Y.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyaporn","family":"Kampeerapappun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n D.","family":"V\u00e9lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"R1","series-title":"J Postgrad Med","first-page":"55","article-title":"Recent advances in the diagnosis of leishmaniasis","volume":"49","author":"Singh","year":"2003"},{"key":"R2","series-title":"Clin Dermatol","first-page":"417","article-title":"Leishmaniasis. Public health aspects and control","volume":"14","author":"Desjeux","year":"1996"},{"key":"R3","series-title":"Lancet","first-page":"1191","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999"},{"key":"R4","series-title":"Leishmaniasis: 2007 update","author":"Panamerican Health Organization","year":"2008"},{"key":"R5","series-title":"PLoS Negl Trop Dis","first-page":"e313","article-title":"Complexities of assessing the disease burden attributable to leishmaniasis","volume":"2","author":"Bern","year":"2008"},{"key":"R6","series-title":"BMJ","first-page":"801","article-title":"Science, medicine, and the future: leishmaniasis","volume":"321","author":"Roberts","year":"2000"},{"key":"R7","series-title":"J Postgrad Med","first-page":"50","article-title":"Cutaneous leishmaniasis: an overview","volume":"49","author":"Hepburn","year":"2003"},{"key":"R8","series-title":"Mem Inst Oswaldo Cruz","first-page":"239","article-title":"Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review","volume":"99","author":"Silveira","year":"2004"},{"key":"R9","series-title":"Br J Dermatol","first-page":"63","article-title":"Cutaneous leishmaniasis in British troops from Belize","volume":"128","author":"Hepburn","year":"1993"},{"key":"R10","series-title":"Am J Trop Med Hyg","first-page":"889","article-title":"Lack of efficacy of mefloquine in the treatment of New World cutaneous leishmaniasis in Colombia","volume":"59","author":"Hendrickx","year":"1998"},{"key":"R11","series-title":"Clin Infect Dis","first-page":"56","article-title":"Topical paromomycin\/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study","volume":"26","author":"Soto","year":"1998"},{"key":"R12","series-title":"Clin Infect Dis","first-page":"684","article-title":"Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years","volume":"24","author":"Berman","year":"1997"},{"key":"R13","series-title":"J Biol Chem","first-page":"33883","article-title":"Inducible resistance to oxidant stress in the protozoan Leishmania chagasi","volume":"275","author":"Miller","year":"2000"},{"key":"R14","series-title":"Clin Exp Dermatol","first-page":"288","article-title":"Nitric oxide and cellular immunity in experimental cutaneous leishmaniasis","volume":"28","author":"Diaz","year":"2003"},{"key":"R15","series-title":"Science","first-page":"951","article-title":"Requirement for type 2 NO synthase for IL-12 signaling in innate immunity","volume":"284","author":"Diefenbach","year":"1999"},{"key":"R16","series-title":"J Immunol","first-page":"893","article-title":"Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi","volume":"167","author":"Gantt","year":"2001"},{"issue":"(Suppl):","key":"R17","series-title":"APMIS","first-page":"1","article-title":"Regulator and effector functions of T-cell subsets in human Leishmania infections","volume":"68","author":"Kemp","year":"1997"},{"key":"R18","series-title":"J Immunol","first-page":"4794","article-title":"Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine","volume":"144","author":"Liew","year":"1990"},{"key":"R19","series-title":"Infect Immun","first-page":"4638","article-title":"Expression of inducible nitric oxide synthase in skin lesions of patients with American cutaneous leishmaniasis","volume":"70","author":"Qadoumi","year":"2002"},{"key":"R20","series-title":"Trans R Soc Trop Med Hyg","first-page":"319","article-title":"A topical nitric oxide-generating therapy for cutaneous leishmaniasis","volume":"94","author":"Davidson","year":"2000"},{"key":"R21","series-title":"Lancet","first-page":"1176","article-title":"Treatment of cutaneous leishmaniasis with nitric-oxide donor","volume":"351","author":"Lopez-Jaramillo","year":"1998"},{"key":"R22","series-title":"Polym Mater Sci Eng","first-page":"508","article-title":"Production of superabsorbent electrospun nanofibers","volume":"90","author":"Hansen","year":"2004"},{"key":"R23","series-title":"Topical Nitric Oxide Donor Devices","author":"Lopez","year":"2006"},{"key":"R24","series-title":"Stabilization and Ionic Triggering of Nitric Oxide Release","author":"Smith","year":"2005"},{"key":"R25","series-title":"J Control Release","first-page":"57","article-title":"Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend","volume":"81","author":"Kenawy","year":"2002"},{"key":"R26","series-title":"Biomaterials","first-page":"907","article-title":"Electrospinning of poly(ethylene-co-vinyl alcohol) fibers","volume":"24","author":"Kenawy","year":"2003"},{"key":"R27","series-title":"Am J Trop Med Hyg","first-page":"648","article-title":"A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran","volume":"53","author":"Asilian","year":"1995"},{"key":"R28","series-title":"Biomedica (Bogota)","first-page":"188","article-title":"Eficacia y tolerancia de la pentamidina en el tratamiento de la leishmaniasis cut\u00e1nea producida por Leishmania (V.) panamensis en Colombia","volume":"26","author":"Robledo","year":"2006"},{"key":"R29","series-title":"Ann Intern Med","first-page":"232","article-title":"Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial","volume":"126","author":"Velez","year":"1997"},{"key":"R30","series-title":"Science","first-page":"473","article-title":"Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite","volume":"235","author":"Hibbs","year":"1987"},{"key":"R31","series-title":"Annu Rev Immunol","first-page":"323","article-title":"Nitric oxide and macrophage function","volume":"15","author":"MacMicking","year":"1997"},{"issue":"(Suppl 2):","key":"R32","series-title":"Clin Infect Dis","first-page":"S162","article-title":"No inhibitions: antimicrobial properties of nitric oxide","volume":"21","author":"De Groote","year":"1995"},{"key":"R33","series-title":"Cancer Res","first-page":"5507","article-title":"Macrophage nitric oxide synthesis delays progression of ultraviolet light-induced murine skin cancers","volume":"53","author":"Yim","year":"1993"},{"key":"R34","series-title":"J Exp Med","first-page":"1543","article-title":"Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells","volume":"169","author":"Stuehr","year":"1989"}],"container-title":["The American Society of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/83\/1\/article-p97.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/83\/1\/article-p97.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/83\/1\/article-p97.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T16:05:46Z","timestamp":1725293146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/83\/1\/article-p97.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":34,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.2010.09-0287","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}